uridine triphosphate has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M; Kanaide, H; Kobayashi, S; Miyagi, Y; Nishimura, J | 1 |
| Brett, SE; Luykenaar, KD; Welsh, DG; Wiehler, WB; Wu, BN | 1 |
| Bény, JL | 1 |
| Busija, DW; Erdös, B; Miller, AW; Simandle, SA; Snipes, JA | 1 |
| Brayden, JE; Corteling, RL; Giles, WR; Luykenaar, KD; Welsh, DG; Wiehler, WB; Wu, BN | 1 |
5 other study(ies) available for uridine triphosphate and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Dual regulation of cerebrovascular tone by UTP: P2U receptor-mediated contraction and endothelium-dependent relaxation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Cattle; Cerebral Arteries; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Indomethacin; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Prostaglandin Endoperoxides, Synthetic; Receptors, Purinergic P2; Thromboxane A2; Uridine Triphosphate; Vasoconstrictor Agents | 1996 |
Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Animals; Cerebral Arteries; Enzyme Inhibitors; Female; Intracellular Signaling Peptides and Proteins; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Potassium Channels; Protein Kinase C; Protein Serine-Threonine Kinases; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; rho-Associated Kinases; Uridine Triphosphate; Vasoconstrictor Agents | 2004 |
Characterization of purine receptors in mouse thoracic aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Aorta, Thoracic; Biological Factors; Calcimycin; Dose-Response Relationship, Drug; Endothelium, Vascular; Male; Mice; Mice, Inbred ICR; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Phenylephrine; Receptors, Purinergic P2; Uridine Triphosphate | 2004 |
Insulin resistance does not impair contractile responses of cerebral arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Blotting, Western; Cerebral Arteries; Dose-Response Relationship, Drug; Insulin Resistance; Male; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Time Factors; Uridine Triphosphate; Vasoconstriction | 2005 |
Hyposmotic challenge inhibits inward rectifying K+ channels in cerebral arterial smooth muscle cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cerebral Arteries; Female; Hypotonic Solutions; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Naphthalenes; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serotonin; Tetradecanoylphorbol Acetate; Uridine Triphosphate; Vasoconstrictor Agents | 2007 |